![Peter Greaney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Peter Greaney worked as the Director of Business Development and Operations at Celgene Corp.
from 2006 to 2018.
He also worked as the Head of Corporate Development at ADC Therapeutics SA. Prior to his professional experience, he earned an undergraduate degree from the University of East Anglia and a doctorate from the University of Nottingham.
Anciens postes connus de Peter Greaney
| Sociétés | Poste | Fin |
|---|---|---|
| CELGENE | Directeur des opérations | 01/01/2018 |
| ADC THERAPEUTICS SA | Corporate Officer/Principal | - |
Formation de Peter Greaney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
University of East Anglia
 University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
